As online idn play technology continues to evolve, many players are drawn to platforms that emphasize accessibility and performance. A reliable situs idn poker generally offers intuitive navigation, secure account protection, and a wide selection of card games. These features help users focus on strategy and entertainment while enjoying a consistent gaming experience across different devices.

Many gaming enthusiasts search for a trusted link idn slot that offers stable connectivity and uninterrupted access to their favorite games. Fast-loading pages, responsive servers, and user-friendly features contribute significantly to player satisfaction. By prioritizing performance and accessibility, the link slot qris creates a comfortable environment where users can focus on enjoying entertainment without unnecessary technical obstacles or delays.

Access to reliable data macau lottery updates allows users to make informed observations based on verified information. The platform emphasizes clarity, speed, and transparency, ensuring that every published result is easy to review. For many visitors, comprehensive result macau resources serve as an essential reference point when exploring historical records and recent draw activity.

S 242 in Congressional Session 110

Official Summary

 

Bill Number : S 242
 

Title : A bill to amend the Federal Food, Drug, and Cosmetic Act with respect to the importation of prescription drugs, and for other purposes.
 

SUMMARY AS OF:
1/10/2007--Introduced. Pharmaceutical Market Access and Drug Safety Act of 2007 - Amends the Federal Food, Drug, and Cosmetic Act (FFDCA) to revise provisions governing the importation of prescription drugs. Waives the limitation on importation of prescription drugs that have been exported from the United States. Prohibits the importation of a qualifying drug unless such drug is imported by: (1) a registered importer; or (2) an individual for personal use. Establishes registration conditions for importers and exporters. Requires the Secretary to inspect places of business, verify chains of custody, inspect facilities, and determine compliance with registration conditions. Sets forth provisions governing the importation of qualifying drugs that are different from U.S. label drugs, including standards for judging such differences. Prohibits manufacturers from: (1) discriminating against registered exporters or importers; (2) causing there to be a difference in a prescription drug distributed in the United States and one distributed in a permitted country; (3) engaging in actions to restrict, prohibit, or delay the importation of a qualifying drug; or (4) engaging in any action that the Federal Trade Commission (FTC) determines discriminates against a person that engages or attempts to engage in the importation of a qualifying drug. States that the resale in the United States of prescription drugs that were properly sold abroad is not patent infringement. Requires the Secretary to educate consumers regarding prescription drug importation. Sets forth provisions governing the sale of prescription drugs through an Internet site. Includes the dispensing or selling of a prescription drug in violation of this Act as a prohibited act under FFDCA. Prohibits the introduction of restricted transactions with unregistered foreign pharmacies into a payment system or the completion of such transactions using a payment system.

Votes

Title : A bill to amend the Federal Food, Drug, and Cosmetic Act with respect to the importation of prescription drugs, and for other purposes.
Votes in the US Senate
This Bill was not Voted in the US Senate
Votes in the US House
This Bill was not Voted in the US House

Sponsors

 
Congressional Sponsors of S 242
 
Bill Number : S 242
Title : A bill to amend the Federal Food, Drug, and Cosmetic Act with respect to the importation of prescription drugs, and for other purposes.
Sponsor: Sen Dorgan, Byron L. [ND] (introduced 1/10/2007)      
ALPHABETICAL [followed by Cosponsors withdrawn]:     (Sort: by date)

Sen Bingaman, Jeff [NM] - 1/10/2007

Sen Boxer, Barbara [CA] - 1/10/2007

Sen Brown, Sherrod [OH] - 1/10/2007

Sen Casey, Robert P., Jr. [PA] - 1/22/2007

Sen Clinton, Hillary Rodham [NY] - 1/10/2007

Sen Collins, Susan M. [ME] - 1/10/2007

Sen Conrad, Kent [ND] - 2/26/2007

Sen Durbin, Richard [IL] - 1/10/2007

Sen Feingold, Russell D. [WI] - 1/10/2007

Sen Feinstein, Dianne [CA] - 1/10/2007

Sen Grassley, Chuck [IA] - 1/10/2007

Sen Inouye, Daniel K. [HI] - 1/10/2007

Sen Johnson, Tim [SD] - 2/27/2007

Sen Kennedy, Edward M. [MA] - 1/10/2007

Sen Kerry, John F. [MA] - 1/10/2007

Sen Klobuchar, Amy [MN] - 7/15/2008

Sen Kohl, Herb [WI] - 1/10/2007

Sen Leahy, Patrick J. [VT] - 1/10/2007

Sen Levin, Carl [MI] - 1/10/2007

Sen Lincoln, Blanche L. [AR] - 1/10/2007

Sen McCain, John [AZ] - 1/10/2007

Sen McCaskill, Claire [MO] - 5/1/2007

Sen Nelson, Bill [FL] - 1/10/2007

Sen Obama, Barack [IL] - 1/10/2007

Sen Pryor, Mark L. [AR] - 1/10/2007

Sen Salazar, Ken [CO] - 1/10/2007

Sen Sanders, Bernard [VT] - 1/10/2007

Sen Schumer, Charles E. [NY] - 1/10/2007

Sen Snowe, Olympia J. [ME] - 1/10/2007

Sen Specter, Arlen [PA] - 1/10/2007

Sen Stabenow, Debbie [MI] - 1/10/2007

Sen Tester, Jon [MT] - 1/10/2007

Sen Thune, John [SD] - 6/11/2007

Sen Webb, Jim [VA] - 5/7/2007

Sen Whitehouse, Sheldon [RI] - 6/12/2007

Sen Wyden, Ron [OR] - 1/10/2007

Other Info

Bill Number : S 242
Title : A bill to amend the Federal Food, Drug, and Cosmetic Act with respect to the importation of prescription drugs, and for other purposes.
 
MAJOR ACTIONS:
***NONE***
 
ALL ACTIONS:
 
1/10/2007:Sponsor introductory remarks on measure. (CR S384-385)
 
1/10/2007:Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
 
3/7/2007:Committee on Commerce, Science, and Transportation Subcommittee on Interstate Commerce, Trade, and Tourism. Hearings held.